Prevalence of Mullerian Anomalies in Infertile Women

Mullerian Anomaly of Uterus Clinical Trial

Official title:

Prevalence of Mullerian Anomalies and PCO in Egyptian Women

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03498079
• Other study ID #: mullerian anomalies
• Status: Recruiting
• Start date: April 16, 2018
• Est. completion date: April 25, 2019

Study information

• Verified date: January 2019
• Source: Aljazeera Hospital
• Contact: Mahmoud Alalfy
• Phone: 01002611058
• Email: mahmoudalalfy[@]ymail.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

• Mullerian anomalies are congenital structural anomalies in the uterus .

• Its prevalence is not uncommon .

Description:

• PCO is very common in gynecological practice

• Women with mullerian anomalies should be properly evaluated for other gynecological and urological problems

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 250
• Est. completion date: April 25, 2019
• Est. primary completion date: April 20, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 20 Years to 40 Years

Eligibility

Inclusion Criteria:

• females with age between 20-42 years with primary infertility

Exclusion Criteria:

• females with age above 42 years or below 20 years females with secondary infertility

Related Conditions & MeSH terms

• Congenital Abnormalities
• Mullerian Anomaly of Uterus

Intervention

Diagnostic Test:
• 3D ultrasound
3D ultrasound will be done to females complaining from primary infertility with mullerian anomalies

Locations

Country	Name	City	State
Egypt	Algazeerah	Giza

Sponsors (4)

Lead Sponsor	Collaborator
Aljazeera Hospital	Kasr El Aini Hospital, misr Infertility centre ,Alaqsor, National Research Center, Egypt

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	the number of participants who will prove to have PCO	diagnosis of PCO by US and by FSH and LH levels	within 4 weeks